Silvestre Carina Carvalho, Santos Lincoln Marques Cavalcante, de Oliveira-Filho Alfredo Dias, de Lyra Divaldo Pereira
Laboratory of Teaching and Research in Social Pharmacy (LEPFS), Department of Pharmacy, Federal University of Sergipe, Cidade Universitária "Prof. José Aloísio Campos", Jardim Rosa Elze, São Cristóvão, Sergipe, CEP: 49100-000, Brazil.
School of Nursery and Pharmacy (ESENFAR), Federal University of Alagoas, Maceió, Alagoas, Brazil.
Int J Clin Pharm. 2017 Oct;39(5):985-988. doi: 10.1007/s11096-017-0519-2.
Medications are perceived as health risk factors, because they might cause damage if used improperly. In this context, an adequate assessment of medication use history should be encouraged, especially in transitions of care to avoid unintended medication discrepancies (UMDs). In a case-controlled study, we investigated potential risk factors for UMDs at hospital admission and found that 150 (42%) of the 358 patients evaluated had one or more UMDs. We were surprised to find that there was no record of a patient and/or relative interview on previous use of medication in 117 medical charts of adult patients (44.8%). Similarly, in the medical charts of 52 (53.6%) paediatric patients, there was no record of parents and/or relatives interviews about prior use of medications. One hundred thirty-seven medical charts of adult patients (52.4%) and seventy-two medical charts of paediatric patients (74.2%) had no record about medication allergies and intolerances. In other words, there was a lack of basic documentation regarding the patient's medication use history. As patients move between settings in care, there is insufficient tracking of verbal and written information related to medication changes, which results in a progressive and cumulative loss of information, as evidenced by problems associated with clinical transfers and medication orders. Proper documentation of medication information during transfer is a key step in the procedure; hence, it should be rightly performed. It remains unclear whether interviews, and other investigations about medication use history have been performed but have not been recorded as health-care data. Therefore, it is crucial to the improvement of medication use safety that documentation of all drug-related information-even if not directly related to the actual event-become routine practice in health-care organizations, since 'what is not written does not exist'.
药物被视为健康风险因素,因为如果使用不当可能会造成损害。在这种情况下,应鼓励对用药史进行充分评估,尤其是在护理转接过程中,以避免意外的用药差异(UMD)。在一项病例对照研究中,我们调查了入院时发生UMD的潜在风险因素,发现358例接受评估的患者中有150例(42%)存在一个或多个UMD。我们惊讶地发现,在117份成年患者的病历(44.8%)中,没有患者和/或亲属关于先前用药情况的访谈记录。同样,在52份儿科患者的病历(53.6%)中,也没有父母和/或亲属关于先前用药情况的访谈记录。137份成年患者的病历(52.4%)和72份儿科患者的病历(74.2%)没有关于药物过敏和不耐受的记录。换句话说,缺乏关于患者用药史的基本记录。随着患者在不同护理机构之间转移,与用药变化相关的口头和书面信息缺乏足够的跟踪,这导致信息逐渐累积丢失,临床转接和用药医嘱相关问题就是明证。转接过程中对用药信息进行妥善记录是该流程的关键步骤;因此,应该正确执行。目前尚不清楚是否进行了关于用药史的访谈及其他调查,但未作为医疗保健数据记录下来。因此,对于提高用药安全至关重要的是,在医疗保健机构中,记录所有与药物相关的信息——即使与实际事件没有直接关联——应成为常规做法,因为“未记录的就不存在”。